Surmodics, Inc.
NASDAQ:SRDX
37.57 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 132.584 | 99.951 | 105.136 | 94.864 | 100.077 | 81.336 | 73.112 | 71.366 | 61.898 | 57.439 | 56.132 | 51.928 | 67.781 | 69.898 | 121.534 | 97.051 | 73.164 | 69.884 | 62.381 | 49.738 | 43.232 | 29.488 | 22.693 | 18.279 | 13.5 | 9.8 |
| Cost of Revenue
| 71.56 | 70.951 | 63.911 | 65.505 | 66.524 | 54.97 | 43.239 | 29.406 | 24.784 | 23.566 | 22.977 | 7.418 | 8.315 | 27.572 | 7.508 | 8.476 | 5.584 | 3.399 | 2.855 | 3.035 | 2.649 | 2.683 | 2.44 | 0.681 | 0.7 | 0.5 |
| Gross Profit
| 61.024 | 29 | 41.225 | 29.359 | 33.553 | 26.366 | 29.873 | 41.96 | 37.114 | 33.873 | 33.155 | 44.51 | 59.466 | 42.326 | 114.026 | 88.575 | 67.58 | 66.485 | 59.526 | 46.703 | 40.583 | 26.805 | 20.253 | 17.598 | 12.8 | 9.3 |
| Gross Profit Ratio
| 0.46 | 0.29 | 0.392 | 0.309 | 0.335 | 0.324 | 0.409 | 0.588 | 0.6 | 0.59 | 0.591 | 0.857 | 0.877 | 0.606 | 0.938 | 0.913 | 0.924 | 0.951 | 0.954 | 0.939 | 0.939 | 0.909 | 0.892 | 0.963 | 0.948 | 0.949 |
| Reseach & Development Expenses
| 9.572 | 9.082 | 46.734 | 50.188 | 52.885 | 40.973 | 31.817 | 18.498 | 16.165 | 15.55 | 15.079 | 14.143 | 30.656 | 17.916 | 24.379 | 40.498 | 28.465 | 20.391 | 16.072 | 12.633 | 11.79 | 9.714 | 7.997 | 6.797 | 5.2 | 4.5 |
| General & Administrative Expenses
| 0 | 46.935 | 30.677 | 28.392 | 23.95 | 24.111 | 20.478 | 18 | 18.025 | 15.297 | 13.859 | 14.025 | 20.545 | 18.451 | 17.2 | 20.816 | 13.643 | 9.931 | 7.705 | 7.099 | 8.153 | 6.382 | 4.69 | 4.246 | 4.3 | 3.1 |
| Selling & Marketing Expenses
| 0 | 0.012 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 51.884 | 46.947 | 30.68 | 28.392 | 23.95 | 24.111 | 20.478 | 18 | 18.025 | 15.297 | 13.859 | 14.025 | 20.545 | 18.451 | 30.383 | 20.816 | 13.643 | 9.931 | 7.705 | 7.099 | 8.153 | 6.382 | 4.69 | 4.246 | 4.3 | 3.1 |
| Other Expenses
| -2.663 | -4.932 | 2.793 | -47.97 | -50.48 | 1.267 | -0.07 | 0.089 | 0.496 | 0.842 | 1.43 | 0.228 | 0.401 | 0 | 0 | 0 | 0 | 0 | 2.487 | 16.497 | 0 | 0 | 0 | 1.222 | 0.8 | 0.7 |
| Operating Expenses
| 55.421 | 51.097 | 33.473 | 30.61 | 26.355 | 26.602 | 22.897 | 20.422 | 18.025 | 15.297 | 13.859 | 28.168 | 51.201 | 36.367 | 54.762 | 61.314 | 42.108 | 30.322 | 26.264 | 36.229 | 19.943 | 16.096 | 12.687 | 12.265 | 10.3 | 8.3 |
| Operating Income
| 5.15 | -22.097 | 6.703 | -1.251 | 6.469 | -8.799 | 7.103 | 16.859 | 19.089 | 18.576 | 18.82 | 16.342 | -17.518 | -14.053 | 57.501 | 27.261 | 9.899 | 36.163 | 2.985 | 10.474 | 20.64 | 10.709 | 7.566 | 5.333 | 2.5 | 1 |
| Operating Income Ratio
| 0.039 | -0.221 | 0.064 | -0.013 | 0.065 | -0.108 | 0.097 | 0.236 | 0.308 | 0.323 | 0.335 | 0.315 | -0.258 | -0.201 | 0.473 | 0.281 | 0.135 | 0.517 | 0.048 | 0.211 | 0.477 | 0.363 | 0.333 | 0.292 | 0.185 | 0.102 |
| Total Other Income Expenses Net
| -3.116 | -0.396 | -0.357 | -0.203 | 1.089 | -7.296 | 0.057 | -4.59 | 0.652 | -0.104 | 1.064 | -0.036 | -24.757 | -26.618 | 0.26 | -0.369 | -10.804 | -0.598 | -31.399 | -15.125 | 1.859 | 1.688 | 3.055 | 1.416 | 1.2 | 0.7 |
| Income Before Tax
| 2.487 | -22.493 | 6.346 | -1.454 | 7.558 | -7.532 | 7.033 | 16.948 | 19.741 | 18.472 | 20.36 | 16.306 | -16.492 | -20.659 | 59.524 | 26.892 | 14.668 | 35.565 | 4.35 | 11.846 | 22.499 | 12.397 | 10.621 | 6.749 | 3.6 | 1.7 |
| Income Before Tax Ratio
| 0.019 | -0.225 | 0.06 | -0.015 | 0.076 | -0.093 | 0.096 | 0.237 | 0.319 | 0.322 | 0.363 | 0.314 | -0.243 | -0.296 | 0.49 | 0.277 | 0.2 | 0.509 | 0.07 | 0.238 | 0.52 | 0.42 | 0.468 | 0.369 | 0.267 | 0.173 |
| Income Tax Expense
| 4.023 | 4.781 | 2.109 | -2.577 | -0.034 | -3.075 | 3.107 | 6.963 | 6.294 | 6.265 | 5.781 | 6.177 | -3.714 | 0.43 | 21.974 | 12.153 | 11.321 | 15.231 | 12.596 | 4.41 | 8.563 | 4.601 | 3.807 | 2.509 | -0.8 | -0.6 |
| Net Income
| -1.536 | -27.274 | 4.237 | 1.123 | 7.592 | -4.457 | 3.926 | 9.985 | 13.447 | 12.031 | 15.167 | 10.231 | -12.778 | -21.089 | 37.55 | 14.739 | 3.346 | 20.334 | -8.246 | 7.436 | 13.936 | 7.796 | 5.109 | 4.24 | 4.4 | 1.6 |
| Net Income Ratio
| -0.012 | -0.273 | 0.04 | 0.012 | 0.076 | -0.055 | 0.054 | 0.14 | 0.217 | 0.209 | 0.27 | 0.197 | -0.189 | -0.302 | 0.309 | 0.152 | 0.046 | 0.291 | -0.132 | 0.15 | 0.322 | 0.264 | 0.225 | 0.232 | 0.326 | 0.163 |
| EPS
| -0.11 | -1.96 | 0.31 | 0.083 | 0.57 | -0.34 | 0.3 | 0.77 | 1.03 | 0.88 | 1.05 | 0.59 | -0.73 | -1.21 | 2.15 | 0.82 | 0.19 | 1.1 | -0.45 | 0.41 | 0.8 | 0.46 | 0.31 | 0.14 | 0.15 | 0.13 |
| EPS Diluted
| -0.11 | -1.96 | 0.3 | 0.081 | 0.55 | -0.34 | 0.29 | 0.76 | 1.01 | 0.87 | 1.03 | 0.59 | -0.73 | -1.21 | 2.15 | 0.8 | 0.18 | 1.09 | -0.45 | 0.41 | 0.78 | 0.44 | 0.29 | 0.13 | 0.14 | 0.12 |
| EBITDA
| 14.578 | -12.955 | 11.594 | 0.967 | 10.332 | 10.818 | 9.268 | 28.639 | 21.738 | 22.237 | 22.548 | 19.307 | 40.167 | 40.395 | 64.916 | 33.701 | 39.102 | 38.937 | 68.394 | 28.936 | 21.52 | 11.022 | 6.169 | 5.139 | 2.1 | 1 |
| EBITDA Ratio
| 0.11 | -0.13 | 0.11 | 0.01 | 0.103 | 0.133 | 0.127 | 0.401 | 0.351 | 0.387 | 0.402 | 0.372 | 0.593 | 0.578 | 0.534 | 0.347 | 0.534 | 0.557 | 1.096 | 0.582 | 0.498 | 0.374 | 0.272 | 0.281 | 0.156 | 0.102 |